Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at...
Aspyra, Inc. (AMEX: APY) today announced that is has given notice to NYSE Amex (the “Exchange”) of its decision to voluntarily delist its common stock from the Exchange and...
Aspyra, Inc. (AMEX: APY) today announced the release of CyberLAB version 7.2.5, for general distribution to existing and new Laboratory Information System customers...
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at...
Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported it has received notice from NYSE Amex LLC (the...
Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Renaissance Radiology Medical Group, Inc., a leading provider of outpatient diagnostic services...
Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported its results of operations for the second quarter...
Aspyra, Inc. (AMEX:APY) announced today that the Company has entered into an agreement with Valley View Regional Hospital (VVRH), a 142-licensed bed facility located in Ada...
Aspyra, Inc. (AMEX:APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported its results of operations for the first quarter...
Aspyra, Inc. (AMEX: APY) announced today that the Company has entered into an agreement with Springfield Clinic, LLP, one of the largest multi-specialty physicians groups in...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Symbole | Prix | Vol. |
|---|---|---|
| KAPAKairos Pharma Ltd | US$ 2,16 (122,68%) | 113,54M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,445 (-0,23%) | 90,34M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,85 (-0,75%) | 68,29M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,41 (-4,17%) | 55,74M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,29 (3,95%) | 50,41M |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
1
